News Focus
News Focus
Followers 79
Posts 2342
Boards Moderated 0
Alias Born 01/31/2014

Re: jesster64 post# 779908

Tuesday, 08/05/2025 9:05:57 PM

Tuesday, August 05, 2025 9:05:57 PM

Post# of 828978
Jesster, Except you did downplay it. I only provided an informational quote from Andrew’s post, information that the NIH tested DCVax on children with metastatic cancer, that it showed great 5-year results, and that it had amazing survival results. And your reply was that information is over 7 years old.

It’s new information to me. And hands down it is critical for DCVax as it moves forward, ie for cancer patients, RWE, and especially inclusion in a CVPV application if that turns out to be the case.

You subsequently state reasons for why, but none of that “approved in 2 months” was in my post or was it in Andrew’s post, that I was replying to.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176529710

Regardless, in reply to your reasons, I think Andrew’s post about CNPV is relevant. Maybe it was posted years prior and I missed it, but I just learned about it from Andrew posting about it today. We are all trying to keep our fingers on the pulse.

On the CNPV application, it’s possible we submitted an application. Who knows, it could be very possible. I think so because DCVax is an ideal candidate and qualified to do so.
- The UK MAA submission demonstrates validation and credibility
- Advent & Sawston facility, and Flaskworks/Eden in process, demonstrates a capability and a supply chain that can be replicated in the US
- Beartrap posted info from SEC docs about potential manufacturing in the US.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=176530900

Sharing thoughts and opinions. To participate in group due diligence. Motto: Do not be a gullible FUDdable investor.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News